The upward trajectory of the single-use bioreactors market is being significantly fueled by the increased production of monoclonal antibodies and recombinant proteins. These bioreactors are becoming increasingly integral to the clinical production of monoclonal antibodies due to their efficiency and reliability.
Moreover, the expansion in the vaccine sector is adding further momentum to the...
The size of Single-Use Bioreactors Market was valued at USD 3.01 billion in 2022. It is projected to reach USD 10.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2% during the forecast period from 2023 to 2030.
Key Market Drivers:
Biopharmaceutical Boom: The rising demand for biopharmaceuticals, including monoclonal antibodies, gene-modified cells,...
Single-Use Bioreactors Market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
Factors such as the increasing adoption of single-use...
single-use bioreactors market was a rapidly growing segment within the biotechnology and pharmaceutical industries. Single-use bioreactors, also known as disposable bioreactors, are a type of bioreactor that is designed for single-use applications, offering various advantages over traditional stainless-steel bioreactors.
Request for Sample PDF @...
Dynamics and Growth Factors
The dynamics and growth factors shaping the single-use bioreactors market are multifaceted and include technological advancements, regulatory trends, market competition, and evolving consumer preferences. Key growth factors include the rising adoption of single-use bioreactors in biopharmaceutical manufacturing, increasing investment in biologics R&D, and...